Ezetimibe Versus Nutraceuticals in Statin-intolerant Patients
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.
Also called NCT01490229
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 100 participants
- Registry
-
NCT01490229
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Italy
- Registry status
- Unknown status
Technical summary
Registry record NCT01490229. Randomized; single masking; primary purpose treatment. Start 2013-01 (registry gives no type); primary completion 2014-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Ezetimibe Versus Nutraceuticals in Statin-intolerant Patients
- Acronym
- ECLIPSE
- Condition
- Coronary Artery Disease
- Intervention (Drug)
- Ezetimibe
- Intervention (Drug)
- Nutraceuticals
- Lead sponsor
- University of Roma La Sapienza
Record details
- Record id
cardio:ct-nct01490229- Content hash
1be9e7a359048704d2cdc19e31bc76e3e3e8cde66f09d865e1d128f65b8994d3